Home » Topics » Disease categories and therapies » Immune

Immune
RSS

PTK inhibitors described by Knoll for immune and bone diseases

Nov. 3, 1998

SB and Corixa expand vaccine collaboration

Oct. 30, 1998

Nasally delivered flu vaccine safe and immunogenic in adults

Oct. 30, 1998

Phase III study evaluates efficacy of tacrolimus in bone marrow transplantation

Oct. 29, 1998

Aquila's malaria vaccine immunogenic and well tolerated in phase I trial

Oct. 28, 1998

Vasogen files for protection of patient-specific treatment of GvHD

Oct. 27, 1998

Simulect gets the go-ahead from the European Commission

Oct. 23, 1998

Astra patents novel immunosuppressive agents

Oct. 22, 1998

Oxo Chemie initiates phase III trial of compound for late-stage HIV infection

Oct. 21, 1998

Ribi, ATL collaborate on the development of improved allergy vaccines

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...